ZKSCAN3 and type 2 diabetes mellitus: In a type 2 diabetes mellitus (T2DM)-related atherosclerosis (AS) model, Nε-carboxyethyl lysine (CEL) inhibited autophagy-related gene expression by promoting the nuclear localization of ZKSCAN3, leading to impaired macrophage autophagy and decreased plaque stability [117].